Synthon Holding
The company started its biopharmaceutical franchise in 2007 and is building a promising portfolio of next generation medicines. Synthon is developing rapidly into a specialty pharmaceutical company, focusing on the therapeutic areas of oncology and auto-immune diseases.
Last updated on
About Synthon Holding
Founded
1991Estimated Revenue
$250M-$500MEmployees
1K-5KCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
28NAICs Code
32Location
City
NijmegenState
GelderlandCountry
NetherlandsTech Stack (78)
